Feedback PLC Bleepa TB Screening Pilot Now Live in Odisha (6695G)
March 31 2022 - 2:00AM
UK Regulatory
TIDMFDBK
RNS Number : 6695G
Feedback PLC
31 March 2022
Feedback plc
Bleepa TB Screening Pilot Now Live in Odisha
-- The 1(st) patient has gone through Bleepa's cloud-based TB
screening pathway at the Evangelical Hospital Khariar, India.
-- The live pilot enables real-world illustration of Bleepa's
capabilities and will strengthen further commercial and partnership
discussions in India.
London, 31 March 2022 : Feedback plc (AIM: FDBK, "Feedback" or
the "Company"), the specialist clinical communication company,
announces that its cloud TB screening service is now live at the
Evangelical Hospital Khariar in Odisha, India.
The service sees digital X-rays securely transmitted via mobile
networks to the cloud where the images are analysed by Feedback's
partner Qure.ai, before being shared with clinicians. Using
Bleepa's pioneering capabilities a screening result can be
available within minutes of an X-ray being acquired, almost
anywhere in India.
The impact of this technology means that TB screening can now be
expanded to rural areas where digital imaging was difficult to
deliver. This enables current TB screening services to reach more
people and grow the number of their existing screening
contracts.
The pilot, run in partnership with Qure.ai and Amazon Web
Services will now move into an evaluative stage where the system
benefits will be measured as patients come through. In parallel the
Company will pursue a number of opportunities to commercialise the
system, leveraging the evidence generated by the pilot.
Annual India Radiological & Imaging Association
Conference
Feedback was delighted to attend the 74th Annual India
Radiological & Imaging Association conference (IRIA 2022),
bringing together thousands of India's top radiologists and
specialists earlier this month. Feedback's Chief Marketing and
Sales Officer Nick Mayhew joined a panel discussion on Global
Radiology Innovations while the Company debuted Bleepa, BleepaBox
and CareLocker.
Dr Tom Oakley, CEO of Feedback, said: "This is a great milestone
for the Company, opening the gateway to a significant market and
the opportunity to transform care for a great many people.
"India has made massive strides in the development and adoption
of medical technology to support the diagnosis and treatment of
diseases. We support India's vision to eliminate TB by 2025, five
years ahead of the UN's SDG goals, and believe that we can make a
significant contribution to help India reach this goal. We are
confident that our pilot programme will demonstrate the value of
Bleepa to rapidly screen for TB, particularly in remote,
resource-scarce locations where this has been a challenge."
Further information on Feedback and its products can be found on
the Company's website:
https://fbkmed.com/feedback-plc/reports-and-presentations/
-Ends-
Enquiries:
Feedback plc +44 (0) 20 3997 7634
Tom Oakley, CEO IR@fbk.com
Anesh Patel, CFO
Panmure Gordon (UK) Limited (NOMAD
and Broker)
Emma Earl/Freddy Crossley (Corporate
Finance)
Rupert Dearden (Corporate Broking) +44 (0)20 7886 2500
Walbrook PR Ltd Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
Paul McManus/Nick Rome/Nicholas 07980 541 893 or 07748 325 236
Johnson or 07884 664 686
About Feedback
Feedback plc is a specialist clinical communications business,
with a mission to improve the efficiency and quality of
communications for frontline clinicians and hospitals with a key
focus on building solutions that enhance access to high quality
patient data.
Feedback has developed a toolkit of clinical communications
apps. Its core, regulatory approved product is Bleepa, a
revolutionary medical imaging app enabling remote and secure
communications between frontline clinicians and teams. CareLocker
is an evolutionary GDPR compliant patient-centric cloud
architecture - its proprietary technology enables an easy route to
creation and mobilisation of individual healthcare records. Bleepa
Box is a specialist tool to enable image transfer from remote
settings to the Bleepa platform over mobile networks.
The Company has a number of growth opportunities domestically
and internationally across a range of markets including the NHS,
the veterinary market and private healthcare providers and its
highly scalable Software as a Service ("SaaS")-based revenue model
is expected to provide increasing levels of visibility as the
Company grows its customer base.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCBRGDXUGXDGDG
(END) Dow Jones Newswires
March 31, 2022 02:00 ET (06:00 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
From Jul 2024 to Jul 2024
Feedback (LSE:FDBK)
Historical Stock Chart
From Jul 2023 to Jul 2024